test

Aryn Sands

@Privium Fund Management B.v.

Latest period2024 - Q3ReportedManaged Assets$402.033MTotal holdings82
Assets growth rate2.54%Assets growth rate (2-Q avg)3.63%Continuous growth in asset value4 quarters

Portfolio positions

This chart displays the top 10 holdings in Privium Fund Management B.v.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 82 positions.

Assets under management

The assets under management (AUM) of Privium Fund Management B.v. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 402.033M in assets, with a quarterly growth rate of 2.54% and a 2-quarter average growth rate of 3.63%. The portfolio is managed by Aryn Sands, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
QUREUniqure Nv
Recent Activity
Increased 16.32%
0.92%
$3.672M
744,916 shares@ $4.94 avg price
MRNAModerna Inc
Recent Activity
Increased 74.04%
0.68%
$2.705M
40,482 shares@ $66.83 avg price
CRSPCrispr Therapeutics Ag
Recent Activity
Increased 10.98%
0.36%
$1.426M
30,347 shares@ $46.98 avg price
RNAAvidity Biosciences Inc
Recent Activity
Increased 15.1%
0.3%
$1.176M
25,600 shares@ $45.93 avg price
FDMT4d Molecular Therapeutics In
Recent Activity
Increased 146.25%
0.27%
$1.065M
98,500 shares@ $10.81 avg price
ALXOAlx Oncology Hldgs Inc
Recent Activity
Increased 28.24%
0.24%
$926,487
509,059 shares@ $1.82 avg price
MGTXMeiragtx Hldgs Plc
Recent Activity
Increased 4.91%
0.23%
$892,213
213,960 shares@ $4.17 avg price
CCitigroup Inc
Recent Activity
Increased 2.62%
0.2%
$801,530
12,804 shares@ $62.6 avg price
FNVFranco Nev Corp
Recent Activity
Increased 155.74%
0.19%
$753,079
6,061 shares@ $124.25 avg price
AUTLAutolus Therapeutics Plc
Recent Activity
Increased 15.57%
0.17%
$673,870
185,639 shares@ $3.64 avg price